• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体瘤与肿瘤微环境的相互作用。

Interplay between Solid Tumors and Tumor Microenvironment.

机构信息

Department of Biochemistry, College of Natural Sciences, and Kangwon Institute of Inclusive Technology, Kangwon National University, Chuncheon, South Korea.

Global/Gangwon Innovative Biologics-Regional Leading Research Center (GIB-RLRC), Kangwon National University, Chuncheon, South Korea.

出版信息

Front Immunol. 2022 May 30;13:882718. doi: 10.3389/fimmu.2022.882718. eCollection 2022.

DOI:10.3389/fimmu.2022.882718
PMID:35707536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9189309/
Abstract

Over the past few decades, basic studies aimed at curing patients with cancer have been constantly evolving. A myriad of mechanistic studies on physiological changes and related factors in tumor growth and metastasis have been reported. Recently, several studies have been considerate to how tumors adapt to unfavorable environments, such as glucose deprivation, oxidative stress, hypoxic conditions, and immune responses. Tumors attempt to adapt to unfavorable environments with genetic or non-genetic changes, the alteration of metabolic signals, or the reconfiguration of their environment through migration to other organs. One of the distinct features in solid tumors is heterogeneity because their environments vary due to the characteristics of colony growth. For this reason, researchers are paying attention to the communication between growing tumors and neighboring environments, including stromal cells, immune cells, fibroblasts, and secreted molecules, such as proteins and RNAs. During cancer survival and progression, tumor cells undergo phenotype and molecular changes collectively referred to as cellular plasticity, which result from microenvironment signals, genetics and epigenetic alterations thereby contributing to tumor heterogeneity and therapy response. In this review, we herein discuss the adaptation process of tumors to adverse environments communication with neighboring cells for overcoming unfavorable growth conditions. Understanding the physiology of these tumors and their communication with the tumor environment can help to develop promising tumor treatment strategies.

摘要

在过去的几十年中,旨在治愈癌症患者的基础研究一直在不断发展。已经报道了大量关于肿瘤生长和转移中生理变化及相关因素的机制研究。最近,有几项研究考虑了肿瘤如何适应不利环境,如葡萄糖剥夺、氧化应激、缺氧条件和免疫反应。肿瘤试图通过遗传或非遗传变化、代谢信号的改变或通过迁移到其他器官来重新配置其环境来适应不利环境。实体瘤的一个显著特征是异质性,因为由于菌落生长的特点,其环境会发生变化。出于这个原因,研究人员正在关注不断生长的肿瘤与包括基质细胞、免疫细胞、成纤维细胞和分泌分子(如蛋白质和 RNA)在内的邻近环境之间的交流。在癌症的存活和进展过程中,肿瘤细胞经历表型和分子变化,统称为细胞可塑性,这是由微环境信号、遗传和表观遗传改变引起的,从而导致肿瘤异质性和治疗反应。在这篇综述中,我们讨论了肿瘤适应不利环境的过程以及与邻近细胞的交流,以克服不利的生长条件。了解这些肿瘤的生理学及其与肿瘤环境的交流有助于开发有前途的肿瘤治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26c8/9189309/96116b3a5750/fimmu-13-882718-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26c8/9189309/b0b3c9f3b387/fimmu-13-882718-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26c8/9189309/96116b3a5750/fimmu-13-882718-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26c8/9189309/b0b3c9f3b387/fimmu-13-882718-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26c8/9189309/96116b3a5750/fimmu-13-882718-g002.jpg

相似文献

1
Interplay between Solid Tumors and Tumor Microenvironment.实体瘤与肿瘤微环境的相互作用。
Front Immunol. 2022 May 30;13:882718. doi: 10.3389/fimmu.2022.882718. eCollection 2022.
2
Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?靶向基质是否能为增强实体瘤抗肿瘤免疫和免疫治疗铺平道路?
Cancer Immunol Res. 2016 Apr;4(4):269-78. doi: 10.1158/2326-6066.CIR-16-0011.
3
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.基质的环境和细胞力学特性调节细胞迁移,并有助于癌细胞的侵袭表型。
Rep Prog Phys. 2019 Jun;82(6):064602. doi: 10.1088/1361-6633/ab1628. Epub 2019 Apr 4.
4
Understanding the role of stromal fibroblasts in cancer progression.了解基质成纤维细胞在癌症进展中的作用。
Cell Adh Migr. 2012 May-Jun;6(3):231-5. doi: 10.4161/cam.20419. Epub 2012 May 1.
5
Fabrication Method of a High-Density Co-Culture Tumor-Stroma Platform to Study Cancer Progression.高密度共培养肿瘤基质平台的构建方法用于研究癌症进展。
Methods Mol Biol. 2021;2258:241-255. doi: 10.1007/978-1-0716-1174-6_16.
6
Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.肿瘤相关成纤维细胞中的自噬促进肿瘤细胞存活:缺氧、HIF1 诱导和 NFκB 激活在肿瘤基质微环境中的作用。
Cell Cycle. 2010 Sep 1;9(17):3515-33. doi: 10.4161/cc.9.17.12928. Epub 2010 Sep 9.
7
Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment.肿瘤微环境中基质-上皮代谢偶联:自噬与代谢的整合。
Int J Biochem Cell Biol. 2011 Jul;43(7):1045-51. doi: 10.1016/j.biocel.2011.01.023. Epub 2011 Feb 15.
8
Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression.癌症与非癌性基质细胞之间的代谢合作在癌症进展中起关键作用。
Tumour Biol. 2018 Feb;40(2):1010428318756203. doi: 10.1177/1010428318756203.
9
Cancer Cells Don't Live Alone: Metabolic Communication within Tumor Microenvironments.癌细胞并非孤立生存:肿瘤微环境中的代谢通讯。
Dev Cell. 2020 Jul 20;54(2):183-195. doi: 10.1016/j.devcel.2020.06.018. Epub 2020 Jul 7.
10
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.糖酵解代谢途径在癌症转移中的双重作用:与复杂的肿瘤微环境的相互作用和新的治疗策略。
Semin Cancer Biol. 2020 Feb;60:238-248. doi: 10.1016/j.semcancer.2019.08.025. Epub 2019 Aug 21.

引用本文的文献

1
Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis.全面的泛癌分析和实验验证表明,FCHSD1是一种用于诊断、免疫浸润和预后的潜在生物标志物。
Front Oncol. 2025 Jun 4;15:1547067. doi: 10.3389/fonc.2025.1547067. eCollection 2025.
2
Comprehensive analysis of FAM83B in pan-cancer and preliminary exploration in esophageal squamous cell carcinoma.FAM83B在泛癌中的综合分析及在食管鳞状细胞癌中的初步探索
J Mol Histol. 2025 May 26;56(3):169. doi: 10.1007/s10735-025-10452-0.
3
Benign non-immune cells in tumor microenvironment.

本文引用的文献

1
Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution.癌症进化的遗传和非遗传机制
Cancers (Basel). 2021 Mar 18;13(6):1380. doi: 10.3390/cancers13061380.
2
Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression.肿瘤进展过程中微环境中基质细胞和免疫格局的重塑
Front Oncol. 2021 Mar 8;11:596798. doi: 10.3389/fonc.2021.596798. eCollection 2021.
3
Targeting tumor-associated macrophages to synergize tumor immunotherapy.靶向肿瘤相关巨噬细胞以协同肿瘤免疫治疗。
肿瘤微环境中的良性非免疫细胞。
Front Immunol. 2025 Apr 3;16:1561577. doi: 10.3389/fimmu.2025.1561577. eCollection 2025.
4
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies.实体瘤中的免疫调节与免疫治疗:耐药机制及潜在治疗策略
Int J Mol Sci. 2025 Mar 24;26(7):2923. doi: 10.3390/ijms26072923.
5
From multi-omics to predictive biomarker: AI in tumor microenvironment.从多组学到预测性生物标志物:肿瘤微环境中的人工智能
Front Immunol. 2024 Dec 23;15:1514977. doi: 10.3389/fimmu.2024.1514977. eCollection 2024.
6
Bladder Cancer Treatments in the Age of Personalized Medicine: A Comprehensive Review of Potential Radiosensitivity Biomarkers.个性化医疗时代的膀胱癌治疗:潜在放射敏感性生物标志物的综合综述
Biomark Insights. 2024 Nov 6;19:11772719241297168. doi: 10.1177/11772719241297168. eCollection 2024.
7
Beyond aromatherapy: can essential oil loaded nanocarriers revolutionize cancer treatment?超越芳香疗法:载有精油的纳米载体能否彻底改变癌症治疗?
Nanoscale Adv. 2024 Sep 27;6(22):5511-62. doi: 10.1039/d4na00678j.
8
Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer.解析胰岛素样生长因子 1 及其异构体在乳腺癌中的作用。
Int J Mol Sci. 2024 Aug 27;25(17):9302. doi: 10.3390/ijms25179302.
9
Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors.与免疫检查点抑制剂原发性耐药相关的基因组和分子改变。
Cancer Immunol Immunother. 2024 Sep 13;73(11):234. doi: 10.1007/s00262-024-03825-z.
10
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression.影响癌症进展中上皮-间充质转化的因素。
Int J Mol Sci. 2024 Aug 17;25(16):8972. doi: 10.3390/ijms25168972.
Signal Transduct Target Ther. 2021 Feb 23;6(1):75. doi: 10.1038/s41392-021-00484-9.
4
The updated landscape of tumor microenvironment and drug repurposing.肿瘤微环境与药物再利用的更新景观。
Signal Transduct Target Ther. 2020 Aug 25;5(1):166. doi: 10.1038/s41392-020-00280-x.
5
A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling.单细胞分析揭示的异质性肿瘤微环境泛癌蓝图。
Cell Res. 2020 Sep;30(9):745-762. doi: 10.1038/s41422-020-0355-0. Epub 2020 Jun 19.
6
Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth.单细胞 RNA 测序揭示了支持肿瘤生长的动态基质龛。
Cell Rep. 2020 May 19;31(7):107628. doi: 10.1016/j.celrep.2020.107628.
7
Interaction between microbiota and immunity in health and disease.肠道菌群与免疫在健康与疾病中的相互作用。
Cell Res. 2020 Jun;30(6):492-506. doi: 10.1038/s41422-020-0332-7. Epub 2020 May 20.
8
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.单细胞 RNA 测序显示转移性肺腺癌的分子和细胞重编程。
Nat Commun. 2020 May 8;11(1):2285. doi: 10.1038/s41467-020-16164-1.
9
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.肿瘤产生的 CXCR1 和 CXCR2 趋化因子受体激动剂诱导中性粒细胞细胞外陷阱,干扰免疫细胞毒性。
Immunity. 2020 May 19;52(5):856-871.e8. doi: 10.1016/j.immuni.2020.03.001. Epub 2020 Apr 13.
10
Tumor microenvironment complexity and therapeutic implications at a glance.肿瘤微环境的复杂性及其治疗意义简述。
Cell Commun Signal. 2020 Apr 7;18(1):59. doi: 10.1186/s12964-020-0530-4.